Today's Updates

NLX-112 Shows Safety and Tolerability in Phase 2a Parkinson Trial, Supporting Further Development Louie Pasculli
Published Date: 25 Jan 2026

A phase 2a trial showed that NLX-112 was safe and well tolerated in patients with Parkinson disease, while also reducing levodopa-induced dyskinesia and motor symptoms, supporting further clinical development.

Read More
AskBio’s Late-Onset Pompe Disease Gene Therapy AB-1009 Cleared for Phase 1/2 Trial Noah Stansfield
Published Date: 25 Jan 2026

AskBio noted that AB-1009 also recently received fast track and orphan drug designations from the FDA.

Read More
Amlitelimab Effective, Safe for Atopic Dermatitis in Patients 12 Years and Older
Published Date: 25 Jan 2026

Amlitelimab Effective, Safe for Atopic Dermatitis in Patients 12 Years and Older

Read More

Latest News


Latest News

News All Time


Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Top Cancer Centers; Phase III Win in Prostate Cancer; Screening Recs for Anal Cancer

2.

AMA President-Elect Confronts a New Challenge: A Brain Tumor

3.

Radiotherapy after mastectomy can be avoided, study finds

4.

For patients with clear cell renal cell carcinoma, a new PET agent allows for same-day imaging.

5.

Base Treatment Decisions in Metastatic Breast Cancer on Presence of ESR1 Mutations



© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot